Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MSL1 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-07 |
mRNA | NANS | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-07 |
mRNA | PLEKHG2 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
mRNA | RP11-795F19.5 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
mRNA | HMGB2 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-07 |
mRNA | ANXA7 | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-07 |
mRNA | FOXJ3 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-07 |
mRNA | MTG2 | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-07 |
mRNA | CRTC1 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |
mRNA | UBTD1 | CTRPv2 | pan-cancer | AAC | -0.19 | 8e-07 |